Drug reference
eribulin
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Oncology (Microtubule Inhibitors)
Mechanism of action
Microtubule inhibitor; inhibits growth phase of microtubules, leading to G2/M cell-cycle block, disruption of mitotic spindles, and, ultimately, apoptotic cell death
Common side effects
- Alopecia
- Asthenia
- Neutropenia
- Anemia
- Fatigue
- Nausea
- Peripheral neuropathy
Related conditions
Frequently asked questions
What drug class is eribulin?
eribulin belongs to: Oncology.
How does eribulin work?
Microtubule inhibitor; inhibits growth phase of microtubules, leading to G2/M cell-cycle block, disruption of mitotic spindles, and, ultimately, apoptotic cell death
What are the common side effects of eribulin?
Alopecia, Asthenia, Neutropenia, Anemia, Fatigue, Nausea, Peripheral neuropathy
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.